Christopher H. Pascoe

Beyond Next Ventures, Inc. (Beyond Next Ventures) is an Independent Venture Capital firm founded in 2014. Beyond Next Ventures, Inc. is headquartered in Tokyo.

Impute Inc. is a Japanese company that focuses on digital therapeutics with AI-based solutions. The company is based in Tokyo, Japan. The company has developed an autism therapy app that provides a digital-therapeutic program for children with autism spectrum disorder (ASD). Impute Inc. was founded in 2017 by Hirofumi Hamanaka, Kunal A. The CEO is Mayank Singh.

RIVERFIELD, Inc. engages in the research, development, and manufacture of medical equipment systems. It specializes in the production and commercialization of surgical robotic support systems for the medical and healthcare industries. The firm also offers endoscopic operation systems. The company was founded on May 20, 2014 and is headquartered in Tokyo, Japan.

University of Tokyo Edge Capital Co Ltd (UTEC) is an independent venture capital firm with headquarters in Japan. UTEC was founded in 2004 and has an office in Tokyo, Japan.

Part of Texas Instruments Incorporated, Texas Instruments Japan Ltd. is a Japanese company that manufactures semiconductor products. The company is based in Tokyo, Japan.

Megakaryon Corp. operates as an pluripotent stem cells research laboratory. It produce platelets and red blood cells from iPS cell lines, and to develop blood products that do not depend on blood donations. The firm specializes in development of technologies to produce and store induced pluripotent stem cell derived human T cells. Megakaryon was founded by Genjiro Miwa on September 9, 2011 and is headquartered in Kyoto, Japan.

Anaeropharma Science, Inc. operates as a holding company that engages in the research and development of therapeutics to target hypoxic environment in solid cancers. It develops bifidobacterium technologies to create anti-cancer drugs. The firm's bifidobacterium therapeutics accumulates to the solid tumor when intravenously injected. The company was founded by Minoru Fujimori and Shunichiro Taniguchi on August 9, 2004 and is headquartered in Tokyo, Japan.

GORYO Chemical, Inc. develops and sells fluorescent probes. It offers Fluorescence imaging, Cancer Targets, in vitro cellular assay, in vivo imaging, cell, Super-Resolution Microscopy, Optical Microscopy, Small Animal Molecular Imaging, Near Infrared Fluorescence, High Content Screening, Molecular Biology and Molecular Diagnostics. The company was founded on July 16, 2010 by Ken-ichi Maruyama and is headquartered in Sapporo, Japan.

Molcure, Inc. operates as a antibody-drug-focused biopharmaceutical company. It develops systems and technologies that enable pharmaceutical companies (developing antibody drugs) to identify antibody candidates. It offers Abtracer, an antibody sequence screening system to detect antibodies; and SmartLabModule, an IoT platform for science. The company was founded by Eli Lyons, Ryu Ogawa, Yoichiro Hara and Yutaro Kyono on May 1, 2013 and is headquartered in Tokyo, Japan.

Provigate KK engages in the development, manufacture and sale of blood glucose level measuring instrument. The company was founded in March 2015 and is headquartered in Tokyo, Japan.

Elixirgen Therapeutics, Inc. operates as a biotechnology company. It develops and sells stem cell therapies for genetic diseases. The company was founded by Akihiro Ko and Minoru S. H. Ko in 2017 and is headquartered in Baltimore, MD.

Adacotech, Inc. is a Japanese company that specializes in the research, development, manufacture, and sales of systems related to video surveillance and automatic recognition. The company is based in Tokyo, Japan. The company was founded in 2012. Ryota Kawamura has been the CEO of the company since 2019.

Part of Bayer AG, Nihon Schering KK is a Japanese company that manufactures pharmaceuticals and diagnostic substances. The company is based in Osaka, Japan.

Genomedia, Inc. is a Japanese company that provides one-stop and high-efficiency genome information analysis services, from sample preparation to software tool development. The company was founded in 2013 and is based in Tokyo, Japan. The company specializes in the development and provision of diagnostic services using genomic information, as well as the development of tools required to perform genome information analysis.

Veolia Japan KK engages in the provision of water, energy and materials solutions focusing on waste receovery. Its services include operation and maintenance of water and wastewater treatment facilities; design, construction, and management of water and wastewater treatment facilities; pipe network management; platic recycling and renewable energy. The company was founded on May 1, 2002 and is headquartered in Tokyo, Japan.

Part of Veolia Environnement SA, Nishihara Environment Technology, Inc. constructs and operates water treatment facilities. The company is based in Tokyo, Japan.

SCOHIA PHARMA, Inc. is a drug discovery venture that focuses on lifestyle-related diseases. The company is based in Fujisawa, Japan. The Japanese company has a strong development pipeline and an experienced R & D team that specializes in drug discovery, including compound creation, drug efficacy evaluation, and clinical development. The CEO of the company is Masanori Watanabe.